AGA临床实践更新:早期结直肠癌的内镜下切除
该AGA专家评论聚焦T1期结直肠癌(肿瘤浸润限于黏膜下层),回顾其定义、内镜下切除的作用、复发与转移风险因素及切除后管理(监测或辅助手术),目标读者包括基层医疗、消化科、病理科和外科医疗专业人员。
要点
- T1期结直肠癌传统上以手术治疗为主。
- 内镜切除技术进步及对肿瘤生物学和淋巴结转移风险的深入理解拓展了治疗选择。
- 评论涵盖T1期结直肠癌定义、内镜切除作用、复发转移风险因素及切除后管理。
核心结论
- 内镜切除技术的进步及对肿瘤生物学、淋巴结转移和复发风险认识的提高,扩展了T1期结直肠癌的治疗手段。
研究设计与样本
- 本文为美国胃肠病学会(AGA)临床实践更新专家评论,由AGA临床实践更新委员会(CPUC)和AGA理事会委托并批准,经CPUC内部同行评议和Gastroenterology标准程序外部同行评议。
临床怎么用
- 目标读者包括基层医疗、消化科、病理科和外科医疗专业人员,内容涉及T1期结直肠癌定义、内镜切除作用、复发转移风险因素及切除后管理(监测或辅助手术)。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
DESCRIPTION: T1 colorectal cancer (CRC), defined as tumor invasion confined to the submucosa, has traditionally been managed by surgery. Advances in endoscopic resection techniques, coupled with an improved understanding of tumor biology and risk of lymph node metastasis and recurrence, have expanded our treatment armamentarium for these lesions. The purpose of this American Gastroenterological Association (AGA) Clinical Practice Update Expert Commentary is to review the definition of T1 CRC, discuss the role of endoscopic resection for these lesions, review factors associated with risk of recurrence and metastasis, and discuss post-resection management, including surveillance or adjuvant surgery. The target audience for this commentary includes primary care, gastroenterology, pathology, and surgical health care professionals. METHODS: This expert commentary was commissioned and approved by the AGA Institute Clinical Practice Updates Committee (CPUC) and the AGA Governing Board to provide timely guidance on a topic of high clinical importance to the AGA membership and underwent internal peer review by the CPUC and external peer review through standard procedures of Gastroenterology.
引用
- Ngamruengphong S, Othman MO, Wang AY, et al. AGA Clinical Practice Update on Endoscopic Resection for Early Colorectal Cancer: Commentary. Gastroenterology. 2025. PMID: 41114683. doi:10.1053/j.gastro.2025.09.001
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。